BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8967725)

  • 1. Molecular etiopathogenesis of esophageal cancers.
    Montesano R; Hollstein M; Hainaut P
    Ann Ist Super Sanita; 1996; 32(1):73-84. PubMed ID: 8967725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Russell SE
    Cancer Res; 1995 Aug; 55(15):3406-11. PubMed ID: 7614480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
    Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
    Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular precursor lesions in oesophageal cancer.
    Montesano R; Hainaut P
    Cancer Surv; 1998; 32():53-68. PubMed ID: 10489623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
    Bennett WP; von Brevern MC; Zhu SM; Bartsch H; Muehlbauer KR; Hollstein MC
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):963-6. PubMed ID: 9367071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and gene expression in esophageal cancer.
    Xu XC
    Methods Mol Biol; 2009; 471():335-60. PubMed ID: 19109788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
    Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
    Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.
    Montesano R; Hollstein M; Hainaut P
    Int J Cancer; 1996 Jun; 69(3):225-35. PubMed ID: 8682592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin intake and risk of subtypes of esophageal cancer in Germany.
    Bollschweiler E; Wolfgarten E; Nowroth T; Rosendahl U; Mönig SP; Hölscher AH
    J Cancer Res Clin Oncol; 2002 Oct; 128(10):575-80. PubMed ID: 12384802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lack of association between adenocarcinoma of the esophagus and gastric surgery: a retrospective study.
    Birgisson S; Rice TW; Easley KA; Richter JE
    Am J Gastroenterol; 1997 Feb; 92(2):216-21. PubMed ID: 9040194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India.
    Katiyar S; Hedau S; Jain N; Kar P; Khuroo MS; Mohanta J; Kumar S; Gopalkrishna V; Kumar N; Das BC
    Cancer Lett; 2005 Jan; 218(1):69-79. PubMed ID: 15639342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
    Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.